These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11007481)

  • 1. Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation.
    Aghazadeh B; Lowry WE; Huang XY; Rosen MK
    Cell; 2000 Sep; 102(5):625-33. PubMed ID: 11007481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoinhibition mechanism of proto-Dbl.
    Bi F; Debreceni B; Zhu K; Salani B; Eva A; Zheng Y
    Mol Cell Biol; 2001 Mar; 21(5):1463-74. PubMed ID: 11238883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic region tyrosines provide access points for allosteric activation of the autoinhibited Vav1 Dbl homology domain.
    Amarasinghe GK; Rosen MK
    Biochemistry; 2005 Nov; 44(46):15257-68. PubMed ID: 16285729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the C-terminal SH3 domain and N-terminal tyrosine phosphorylation in regulation of Tim and related Dbl-family proteins.
    Yohe ME; Rossman K; Sondek J
    Biochemistry; 2008 Jul; 47(26):6827-39. PubMed ID: 18537266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
    Heo J; Thapar R; Campbell SL
    Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
    Crespo P; Schuebel KE; Ostrom AA; Gutkind JS; Bustelo XR
    Nature; 1997 Jan; 385(6612):169-72. PubMed ID: 8990121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and Sos1 regulates Rac binding.
    Das B; Shu X; Day GJ; Han J; Krishna UM; Falck JR; Broek D
    J Biol Chem; 2000 May; 275(20):15074-81. PubMed ID: 10748082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vav2 is an activator of Cdc42, Rac1, and RhoA.
    Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
    J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the selective activation of Rho GTPases by Dbl exchange factors.
    Snyder JT; Worthylake DK; Rossman KL; Betts L; Pruitt WM; Siderovski DP; Der CJ; Sondek J
    Nat Struct Biol; 2002 Jun; 9(6):468-75. PubMed ID: 12006984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42.
    Movilla N; Dosil M; Zheng Y; Bustelo XR
    Oncogene; 2001 Dec; 20(56):8057-65. PubMed ID: 11781818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lck regulates Vav activation of members of the Rho family of GTPases.
    Han J; Das B; Wei W; Van Aelst L; Mosteller RD; Khosravi-Far R; Westwick JK; Der CJ; Broek D
    Mol Cell Biol; 1997 Mar; 17(3):1346-53. PubMed ID: 9032261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An SH2 domain-dependent, phosphotyrosine-independent interaction between Vav1 and the Mer receptor tyrosine kinase: a mechanism for localizing guanine nucleotide-exchange factor action.
    Mahajan NP; Earp HS
    J Biol Chem; 2003 Oct; 278(43):42596-603. PubMed ID: 12920122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins.
    Movilla N; Bustelo XR
    Mol Cell Biol; 1999 Nov; 19(11):7870-85. PubMed ID: 10523675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95vav, in platelets.
    Cichowski K; Brugge JS; Brass LF
    J Biol Chem; 1996 Mar; 271(13):7544-50. PubMed ID: 8631786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of proto-Dbl by intracellular membrane targeting and protein stability.
    Vanni C; Mancini P; Gao Y; Ottaviano C; Guo F; Salani B; Torrisi MR; Zheng Y; Eva A
    J Biol Chem; 2002 May; 277(22):19745-53. PubMed ID: 11907027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
    Wang L; Zhu K; Zheng Y
    Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and mutagenesis of the Dbl homology domain.
    Aghazadeh B; Zhu K; Kubiseski TJ; Liu GA; Pawson T; Zheng Y; Rosen MK
    Nat Struct Biol; 1998 Dec; 5(12):1098-107. PubMed ID: 9846881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cdc42 mutant specifically activated by intersectin.
    Smith WJ; Hamel B; Yohe ME; Sondek J; Cerione RA; Snyder JT
    Biochemistry; 2005 Oct; 44(40):13282-90. PubMed ID: 16201754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of the pleckstrin homology and cysteine-rich domains in Vav signaling and transforming activity.
    Palmby TR; Abe K; Der CJ
    J Biol Chem; 2002 Oct; 277(42):39350-9. PubMed ID: 12177050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.